2022 Q3 Form 10-Q Financial Statement

#000164033422001591 Filed on July 27, 2022

View on sec.gov

Income Statement

Concept 2022 Q3 2022 Q2 2022 Q1
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $9.150K $9.500K $19.30K
YoY Change 21.03% 79.25% 13.2%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $9.150K -$9.635K $19.30K
YoY Change 21.03% -2.0% 13.2%
Operating Profit -$9.142K -$9.728K
YoY Change -7.96% -0.02%
Interest Expense $9.142K $9.635K $9.728K
YoY Change -7.96% -2.0% -0.02%
% of Operating Profit
Other Income/Expense, Net -$9.142K -$9.635K -$9.728K
YoY Change
Pretax Income -$18.29K -$19.14K -$29.03K
YoY Change 4.57% 26.5% 8.4%
Income Tax
% Of Pretax Income
Net Earnings -$18.29K -$19.14K -$29.03K
YoY Change 4.57% 26.45% 8.39%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$617.20 -$705.60 -$1.394K
COMMON SHARES
Basic Shares Outstanding 27.82M shares 27.82M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2022 Q3 2022 Q2 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $0.00 $0.00 $0.00
Short-Term Investments
Other Short-Term Assets $0.00 $0.00 $0.00
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $0.00 $0.00 $0.00
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00 $0.00 $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $0.00 $0.00 $0.00
Total Long-Term Assets $0.00 $0.00 $0.00
Total Assets $0.00 $0.00 $0.00
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $56.61K $59.61K $57.51K
YoY Change -0.4% 11.09% 2.4%
Accrued Expenses $87.94K $162.8K $153.7K
YoY Change -34.98% 29.26% 31.72%
Deferred Revenue
YoY Change
Short-Term Debt $72.41K $0.00 $0.00
YoY Change
Long-Term Debt Due $155.6K $155.6K $157.6K
YoY Change -0.46% -0.08% 273.9%
Total Short-Term Liabilities $456.6K $438.3K $421.7K
YoY Change 21.13% 21.93% 82.3%
LONG-TERM LIABILITIES
Long-Term Debt $67.33K $67.33K $67.33K
YoY Change 0.0% 0.0% -62.66%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $67.33K $67.33K $67.33K
YoY Change 0.0% 0.0% -62.66%
TOTAL LIABILITIES
Total Short-Term Liabilities $456.6K $438.3K $421.7K
Total Long-Term Liabilities $67.33K $67.33K $67.33K
Total Liabilities $523.9K $505.6K $489.0K
YoY Change 17.93% 18.47% 18.79%
SHAREHOLDERS EQUITY
Retained Earnings -$233.3M -$233.3M
YoY Change 81.13%
Common Stock $237.9M $237.9M $104.3M
YoY Change 85.26%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$523.9K -$505.6K -$489.0K
YoY Change
Total Liabilities & Shareholders Equity $0.00 $0.00 $0.00
YoY Change

Cashflow Statement

Concept 2022 Q3 2022 Q2 2022 Q1
OPERATING ACTIVITIES
Net Income -$18.29K -$19.14K -$29.03K
YoY Change 4.57% 26.45% 8.39%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$12.15K -$7.400K -$17.90K
YoY Change 177.4% -5.13% 9.82%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 12.15K 7.400K $17.90K
YoY Change 177.4% -5.13% 9.82%
NET CHANGE
Cash From Operating Activities -12.15K -7.400K -$17.90K
Cash From Investing Activities
Cash From Financing Activities 12.15K 7.400K $17.90K
Net Change In Cash 0.000 0.000 $0.00
YoY Change
FREE CASH FLOW
Cash From Operating Activities -$12.15K -$7.400K -$17.90K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0001619227
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
27819385 shares
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
333-199193
dei Entity Registrant Name
EntityRegistrantName
Cloudweb, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
FL
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
47-0978297
dei Entity Address Address Line1
EntityAddressAddressLine1
800 W El Camino Real Suite 180
dei Entity Address City Or Town
EntityAddressCityOrTown
Mountain View
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
CY2022Q2 clow Weighted Average Number Of Common Share Outstanding Basic And Diluted
WeightedAverageNumberOfCommonShareOutstandingBasicAndDiluted
27124940 shares
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
94040
dei City Area Code
CityAreaCode
713
dei Local Phone Number
LocalPhoneNumber
583-6813
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
27819385 shares
CY2022Q2 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
0 usd
CY2021Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
1184 usd
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
27819385 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
319385 shares
CY2022Q2 us-gaap Investment Company Distributable Earnings Loss Accumulated Long Term Capital Gain Loss
InvestmentCompanyDistributableEarningsLossAccumulatedLongTermCapitalGainLoss
-96216 usd
CY2022Q2 us-gaap Professional Fees
ProfessionalFees
9500 usd
CY2021Q2 us-gaap Professional Fees
ProfessionalFees
5300 usd
us-gaap Professional Fees
ProfessionalFees
28800 usd
us-gaap Professional Fees
ProfessionalFees
22350 usd
CY2022Q2 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
9500 usd
CY2021Q2 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
5300 usd
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
28800 usd
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
22350 usd
CY2022Q2 us-gaap Interest Expense
InterestExpense
9635 usd
CY2021Q2 us-gaap Interest Expense
InterestExpense
9832 usd
us-gaap Interest Expense
InterestExpense
19363 usd
us-gaap Interest Expense
InterestExpense
19562 usd
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
-9635 usd
CY2021Q2 us-gaap Operating Expenses
OperatingExpenses
-9832 usd
us-gaap Operating Expenses
OperatingExpenses
-19363 usd
us-gaap Operating Expenses
OperatingExpenses
-19562 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-19135 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-15132 usd
us-gaap Net Income Loss
NetIncomeLoss
-48163 usd
us-gaap Net Income Loss
NetIncomeLoss
-41912 usd
CY2022Q2 clow Earnings Per Common Share Basic And Diluted
EarningsPerCommonShareBasicAndDiluted
-0.00
CY2021Q2 clow Earnings Per Common Share Basic And Diluted
EarningsPerCommonShareBasicAndDiluted
-0.05
clow Earnings Per Common Share Basic And Diluted
EarningsPerCommonShareBasicAndDiluted
-0.00
clow Earnings Per Common Share Basic And Diluted
EarningsPerCommonShareBasicAndDiluted
-0.13
CY2021Q2 clow Weighted Average Number Of Common Share Outstanding Basic And Diluted
WeightedAverageNumberOfCommonShareOutstandingBasicAndDiluted
315703 shares
clow Weighted Average Number Of Common Share Outstanding Basic And Diluted
WeightedAverageNumberOfCommonShareOutstandingBasicAndDiluted
23999940 shares
clow Weighted Average Number Of Common Share Outstanding Basic And Diluted
WeightedAverageNumberOfCommonShareOutstandingBasicAndDiluted
315703 shares
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-459946 usd
CY2022Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
0 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-29028 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-488974 usd
CY2022Q2 clow Share Issuance For Repayment Of Convertible Note Amount
ShareIssuanceForRepaymentOfConvertibleNoteAmount
2500 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-19135 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
18362 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-25300 usd
CY2021 clow Less Current Portion Of Promissory Note Payable
LessCurrentPortionOfPromissoryNotePayable
-2160 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-505609 usd
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-384858 usd
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-26780 usd
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
-411638 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-15132 usd
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
-426770 usd
us-gaap Net Income Loss
NetIncomeLoss
-48163 usd
us-gaap Net Income Loss
NetIncomeLoss
-41912 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
1184 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
1197 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
3497 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-1747 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
18182 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-24100 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
25300 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
24100 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
25300 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
24100 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
0 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
0 usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
0 usd
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
0 usd
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
0 usd
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
0 usd
us-gaap Interest Paid Net
InterestPaidNet
0 usd
us-gaap Interest Paid Net
InterestPaidNet
0 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
0 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
0 usd
us-gaap Share Based Compensation
ShareBasedCompensation
104250000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
0 usd
clow Debt Conversion Converted Instrument Shares Issued Amount
DebtConversionConvertedInstrumentSharesIssuedAmount
2500 usd
clow Debt Conversion Converted Instrument Shares Issued Amount
DebtConversionConvertedInstrumentSharesIssuedAmount
0 usd
clow Longterm Promissory Notes Payable
LongtermPromissoryNotesPayable
67326 usd
CY2021 clow Longterm Promissory Notes Payable
LongtermPromissoryNotesPayable
67326 usd
CY2022Q2 clow Original Discount
OriginalDiscount
0 usd
us-gaap Debt Instrument Increase Accrued Interest
DebtInstrumentIncreaseAccruedInterest
78479 usd
CY2021 us-gaap Debt Instrument Increase Accrued Interest
DebtInstrumentIncreaseAccruedInterest
67672 usd
CY2021Q4 clow Less Debt Discount
LessDebtDiscount
-1184 usd
CY2021Q4 clow Original Discount
OriginalDiscount
1184 usd
CY2022Q2 us-gaap Deposit Liabilities Accrued Interest
DepositLiabilitiesAccruedInterest
84296 usd
CY2022Q2 us-gaap Convertible Debt
ConvertibleDebt
153482 usd
CY2021Q4 us-gaap Convertible Debt
ConvertibleDebt
154798 usd
us-gaap Use Of Estimates
UseOfEstimates
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date the financial statements and the reported amount of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p>
CY2021Q4 us-gaap Deposit Liabilities Accrued Interest
DepositLiabilitiesAccruedInterest
76921 usd
us-gaap Stock Issued During Period Shares Conversion Of Convertible Securities
StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
55327097 shares
us-gaap Stock Issued During Period Shares Conversion Of Convertible Securities
StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
57827097 shares
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
25300 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
24100 usd
CY2022Q2 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
60260 usd
CY2021Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
34960 usd
clow Total Promissory Notes Payable
TotalPromissoryNotesPayable
69486 usd
CY2021 clow Total Promissory Notes Payable
TotalPromissoryNotesPayable
69486 usd
clow Less Current Portion Of Promissory Note Payable
LessCurrentPortionOfPromissoryNotePayable
-2160 usd
CY2022Q2 clow Less Debt Discount
LessDebtDiscount
0 usd
CY2022Q2 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
153482 usd
CY2021Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
154798 usd
CY2022Q2 clow Less Current Portion Of Convertible Note Payable
LessCurrentPortionOfConvertibleNotePayable
-153482 usd
CY2021Q4 clow Less Current Portion Of Convertible Note Payable
LessCurrentPortionOfConvertibleNotePayable
-154798 usd
CY2022Q2 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
0 usd
CY2021Q4 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
0 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
1184 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
1197 usd
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2022Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
25000000 shares
CY2022Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
104250000 usd
CY2022Q2 clow Convertible Note
ConvertibleNote
2500 usd
CY2022Q2 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
2.10
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
27819385 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
319385 shares
CY2022Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
162775 usd
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
144593 usd
CY2022Q2 us-gaap Long Term Notes Payable
LongTermNotesPayable
67326 usd
CY2022Q2 clow Stock Payable
StockPayable
0 usd

Files In Submission

Name View Source Status
0001640334-22-001591-index-headers.html Edgar Link pending
0001640334-22-001591-index.html Edgar Link pending
0001640334-22-001591.txt Edgar Link pending
0001640334-22-001591-xbrl.zip Edgar Link pending
clow-20220630.xsd Edgar Link pending
clow-20220630_cal.xml Edgar Link unprocessable
clow-20220630_def.xml Edgar Link unprocessable
clow-20220630_lab.xml Edgar Link unprocessable
clow-20220630_pre.xml Edgar Link unprocessable
clow_10q.htm Edgar Link pending
clow_10q_htm.xml Edgar Link completed
clow_ex311.htm Edgar Link pending
clow_ex321.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending